MedPath

Theravance Biopharma Inc

Theravance Biopharma Inc logo
🇰🇾Cayman Islands
Ownership
Public
Established
1996-01-01
Employees
251
Market Cap
$409.9M
Website
http://www.theravance.com

Clinical Trials

17

Active:15
Completed:2

Trial Phases

3 Phases

Phase 1:7
Phase 2:1
Phase 3:1

Drug Approvals

1

FDA:1

Drug Approvals

Vibativ

Approval Date
Mar 31, 2014
FDA

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Phase 1
7 (77.8%)
Phase 2
1 (11.1%)
Phase 3
1 (11.1%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.